Cargando…
Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays
The DNA damage response (DDR) pathway regulates DNA repair and cell survival, and inactivating mutations in DDR genes can increase tumour mutational burden (TMB), a predictive biomarker of treatment benefit from anti-PD-1/PD-L1 immunotherapies. However, a better understanding of the relationship amo...
Autores principales: | Wang, Danyi, Elenbaas, Brian, Murugesan, Karthikeyan, Shah, Kunal, Montesion, Meagan, Gounaris, Ioannis, Scheuenpflug, Juergen, Locatelli, Giuseppe, Feng, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567713/ https://www.ncbi.nlm.nih.gov/pubmed/37821580 http://dx.doi.org/10.1038/s41698-023-00442-4 |
Ejemplares similares
-
Fit-for-purpose quantitative liquid biopsy based droplet digital PCR assay development for detection of programmed cell death ligand-1 (PD-L1) RNA expression in PAXgene blood samples
por: O’Rourke, Dennis, et al.
Publicado: (2021) -
Pan-cancer landscape of CD274 (PD-L1) rearrangements in 283,050 patient samples, its correlation with PD-L1 protein expression, and immunotherapy response
por: Kelly, Andrew D, et al.
Publicado: (2021) -
Development of a liquid biopsy based purely quantitative digital droplet PCR assay for detection of MLH1 promoter methylation in colorectal cancer patients
por: Wang, Danyi, et al.
Publicado: (2021) -
Implementing TMB measurement in clinical practice: considerations on assay requirements
por: Büttner, Reinhard, et al.
Publicado: (2019) -
A bipartite graph-based expected networks approach identifies DDR genes not associated with TMB yet predictive of immune checkpoint blockade response
por: Weir, William H., et al.
Publicado: (2022)